Abstract
Lithium (Li) administration causes deranged expression and function of renal aquaporins and sodium channels/transporters resulting in nephrogenic diabetes insipidus (NDI). Extracellular nucleotides (ATP/ADP/UTP), via P2 receptors, regulate these transport functions. We tested whether clopidogrel bisulfate (CLPD), an antagonist of ADP-activated P2Y12 receptor, would affect Li-induced alterations in renal aquaporins and sodium channels/transporters. Adult mice were treated for 14 days with CLPD and/or Li and euthanized. Urine and kidneys were collected for analysis. When administered with Li, CLPD ameliorated polyuria, attenuated the rise in urine prostaglandin E2 (PGE2), and resulted in significantly higher urinary arginine vasopressin (AVP) and aldosterone levels as compared to Li treatment alone. However, urine sodium excretion remained elevated. Semi-quantitative immunoblotting revealed that CLPD alone increased renal aquaporin 2 (AQP2), Na-K-2Cl cotransporter (NKCC2), Na-Cl cotransporter (NCC), and the subunits of the epithelial Na channel (ENaC) in medulla by 25–130 %. When combined with Li, CLPD prevented downregulation of AQP2, Na-K-ATPase, and NKCC2 but was less effective against downregulation of cortical α- or γ-ENaC (70 kDa band). Thus, CLPD primarily attenuated Li-induced downregulation of proteins involved in water conservation (AVP-sensitive), with modest effects on aldosterone-sensitive proteins potentially explaining sustained natriuresis. Confocal immunofluorescence microscopy revealed strong labeling for P2Y12-R in proximal tubule brush border and blood vessels in the cortex and less intense labeling in medullary thick ascending limb and the collecting ducts. Therefore, there is the potential for CLPD to be directly acting at the tubule sites to mediate these effects. In conclusion, P2Y12-R may represent a novel therapeutic target for Li-induced NDI.
Similar content being viewed by others
References
Rieg T, Bundey RA, Chen Y, Deschens G, Junger W, Insel PA, Vallon V (2007) Mice lacking P2Y2 receptors have salt-resistant hypertension and facilitated renal Na+ and water reabsorption. FASEB J 21:3717–3726. doi:10.1096/fj.07-8807com
Zhang Y, Sands JM, Kohan DE, Nelson RD, Martin CF, Carlson NG, Kamerath CD, Ge Y, Klein JD, Kishore BK (2008) Potential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout mice. Am J Physiol Renal Physiol 295:F1715–F1724. doi:10.1152/ajprenal.90311.2008
Wildman SS, Marks J, Turner CM, Yew-booth L, Peppiat-Wildman CM, King BF, Shirley DG, Wang W, Unwin RJ (2008) Sodium-dependent regulation of renal amiloride-sensitive currents by apical P2 receptors. J Am Soc Nephrol 19:731–742. doi:10.1681/ASN.2007040443
Vallon V (2008) P2 receptors in the regulation of renal transport mechanisms. Am J Physiol Ren Physiol 294:F10–F27. doi:10.1152/ajprenal.00432.2007
Kishore BK, Nelson RD, Miller RL, Carlson NG, Kohan DE (2009) P2Y2 receptors and water transport in the kidney. Puriner Signal 5:491–499. doi:10.1007/s11302-009-9151-5
Prætorius H, Leipziger J (2010) Intrarenal purinergic signaling in the control or renal tubular transport. Annu Rev Physiol 72:377–393. doi:10.1146/annurev-physiol-021909-135825
Vallon V, Rieg T (2011) Regulation of renal transport mechanisms. Am J Physiol Ren Physiol 301:F463–F475
Leipziger J (2011) Luminal nucleotides are tonic inhibitors of renal tubular transport. Curr Opin Nephrol Hypertens 20:518–522. doi:10.1097/MNH.0b013e3283487393
Toney GM, Vallon V, Stockand JD (2012) Intrinsic control of sodium excretion in the distal nephron by inhibitory purinergic regulation of the epithelial Na+ channel. Curr Opin Nephrol Hypertens 21:52–60. doi:10.1097/MNH.0b013e32834db4a0
Wildman SSP, Kang ESK, King BF (2009) ENaC, renal sodium excretion and extracellular ATP. Purinergic Signal 5:481–489. doi:10.1007/s11302-009-9150-6
Stockand JD, Mironova E, Bugaj V, Rieg T, Insel PA, Vallon V, Peti-Peterdi J, Pochynyuk O (2010) Purinergic inhibition of ENaC produces aldosterone escape. J Am Soc Nephrol 21:1903–1911. doi:10.1681/ASN.2010040377
Zhang Y, Pop IL, Carlson NG, Kishore BK (2012) Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling. Am J Physiol Ren Physiol 302:F70–F77. doi:10.1152/ajprenal.00444.2011
Zhang Y, Li L, Kohan DE, Ecelbarger CM, Kishore BK (2013) Attenuation of lithium-induced natriuresis and kaliuresis in P2Y2 receptor knockout mice. Am J Physiol Ren Physiol 305:F407–F416. doi:10.1152/ajprenal.00464.2012
Zhang Y, Morris KL, Sparrow SK, Dwyer KM, Enjyoji K, Robson SC, Kishore BK (2012) Defective renal water handling in transgenic mice over-expressing human CD30/NTPDase1. Am J Physiol Ren Physiol 303:F420–F430. doi:10.1152/ajprenal.00060.2012
Zhang Y, Robson SC, Morris KL, Heiney KM, Dwyer KM, Kishore BK, Ecelbarger CM (2015) Impaired natriuretic response to high-NaCl diet plus aldosterone infusion in mice over-expressing human CD39, an ectonucleotidase (NTPDase1). Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00125.2014 [Epub ahead of print]
Grünfeld JP, Rossier BC (2009) Lithium nephrotoxicity revisited. Nat Rev Nephrol 5:270–276. doi:10.1038/nrneph.2009.43
Kishore BK, Ecelbarger CM (2013) Lithium: a versatile tool for understanding renal physiology. Am J Physiol Ren Physiol 304:F1139–F1149. doi:10.1152/ajprenal.00718.2012
Dorsam R, Kunapalli SP (2004) Central role of the P2Y12 receptor in platelet activation. J Clin Invest 113:340–345. doi:10.1172/JCI200420986
Pausch MH, Lai M, Tseng E, Paulsen J, Bates N, Kwak S (2004) Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiae. Biochi Biophys Res Commun 324:171–177. doi:10.1016/j.bbrc.2004.09.034
Zhang Y, Peti-Peterdi J, Müller CE, Carlson NG, Baqi Y, Strasburg DL, Heiney KM, Villanueva K, Kohan DE, Kishore BK (2015) P2Y12 receptor localizes in the renal collecting duct and its blockade augments arginine vasopressin action and alleviates nephrogenic diabetes insipidus. J Am Soc Nephrol Pii: ASN.2014010118. [Epub ahead of print]
Zhang Y, Nelson RD, Carlson NG, Kamerath CD, Kohan DE, Kishore BK (2009) Potential role of purinerigic signaling in lithium-induced nephrogenic diabetes insipidus. Am J Physiol Ren Physiol 296:F1194–F1201. doi:10.1152/ajprenal.90774.2008
Reagan-Shaw S, Nihal M, Ahmad N (2007) Dose translation from animal to human studies revisted. FASEB J 22:659–661. doi:10.1096/fj.07-9574LSF
Reist M, Rou-de Vos M, Montseny JP, Mayer KM, Carrupt PA, Berger Y, Testa B (2000) Very slow chiral inversion of clopidogrel in rats: a pharmacokinetic and mechanistic investigation. Drug Metab Disp 28:1405–1410
Zhang Y, Kohan DE, Nelson RD, Carlson NG, Kishore BK (2010) Potential involvement of P2Y2 receptor in diuresis of postobstructive uropathy in rats. Am J Physiol Ren Physiol 298:F634–F642. doi:10.1152/ajprenal.00382.2009
Zhang Y, Listhrop R, Ecelbarger CM, Kishore BK (2011) Renal sodium transporter/channel expression and sodium excretion in P2Y2 receptor knockout mice fed high-NaCl diet with/without aldosterone infusion. Am J Physol Ren Physiol 300:F567–F668. doi:10.1152/ajprenal.00549.2010
Hanner F, Lan L, Nguyen TX, Yu A, Peti-Peterdi J (2012) Intrarenal localization of the plasma membrane channel pannexin 1. Am J Physiol Ren Physiol 303:F1454–F1459. doi:10.1152/ajprenal.00206.2011
Kishore BK, Zhang Y, Gevorgyan H, Kohan DE, Schiedel AC, Müller CE, Peti-Peterdi J (2013) Cellular localization of adenine receptors in the rat kidney and their functional significance in the inner medullary collecting duct. Am J Physiol Ren Physiol 305:F1298–F1305. doi:10.1152/ajprenal.00254.2013
Allen HM, Jackson RL, Winchester MD, Deck LV, Allon M (1989) Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Arch Intern Med 149:1123–1126. doi:10.1001/archinte.1989.00390050095019
Sugawara M, Hashimot K, Ota Z (1988) Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria. Am J Physiol Regul Integr Comp Physiol 254:R863–R869
Mironova E, Boiko N, Bugai V, Kucher V, Stockand JD (2015) Regulation of Na+ excretion and arterial blood pressure by purinergic signalling intrinsic to the distal nephron: consequences and mechanisms. Acta Physiol 213:213–221. doi:10.1111/apha.12372
McDonough AA (2010) Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. Am J Physiol Regul Integr Comp Physiol 298:R851–R861. doi:10.1152/ajpregu.00002.2010
Knepper MA, Kim G-H, Fernández-Llama ECA (1999) Regulation of thick ascending limb transport by vasopressin. J Am Soc Nephrol 10:628–634
Ecelbarger CA, Kim GH, Wade JB, Knepper MA (2001) Regulation of the abundance of renal sodium transporters and channels by vasopressin. Exp Nephrol 171:227–234. doi:10.1006/exnr.2001.7775
Ares GR, Caceres PS, Ortiz PA (2011) Molecular regulation of NKCC2 in the thick ascending limb. Am J Physiol Ren Physiol 301:F1143–F1159. doi:10.1152/ajprenal.00396.2011
Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA (1998) The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci U S A 95:14552–1455. doi:10.1073/pnas.95.24.14552
Eladari D, Chambrey R, Picard N, Hadchouel J (2014) Electrochemical absorption of NaCl by the aldosterone-sensitive distal nephron: implications for normal electrolytes homeostasis and blood pressure regulation. Cell Mol Life Sci 71:2879–2895
Mutig K, Saritas T, Uchida S, Kahl T, Borowski T, Paliege A, Böhlick A, Bleich M, Shan Q, Bachmann S (2010) Short-term stimulation of the thiazide-sensitive Na+-Cl− cotransporter by vasopressin involves phosphorylation and membrane translocation. Am J Physiol Ren Physiol 298:F502–F509. doi:10.1152/ajprenal.00476.2009
Nielsen J, Kwon TH, Frøkiær J, Knepper MA, Nielsen S (2006) Lithium-induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD. Am J Physiol Ren Physiol 290:F1222–F1233. doi:10.1152/ajprenal.00321.2005
Kortenoeven ML, Li Y, Shaw S, Gaeggeler HP, Rossier BC, Wetzels JF, Deen PM (2009) Amiloride blocks lithium entry through sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int 76:44–53. doi:10.1038/ki.2009.91
Christensen BM, Zuber AM, Loffing J, Stehle JC, Deen PM, Rossier BC, Hummler E (2011) alpha-ENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus. J Am Soc Nephrol 22:253–261. doi:10.1681/ASN.2010070734
Kortenoeven ML, Schweer H, Cox R, Wetzels JF, Deen PM (2012) Lithium reduces aquaporin-2 transcription independent of prostaglandins. Am J Physiol Cell Physiol 302:C131–C140. doi:10.1152/ajpcell.00197.2011
Nicco C, Wittner M, DiStefano A, Jounier S, Bankir S, Bouby N (2001) Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung. Hypertens 38:1143–1149. doi:10.1161/hy1001.092641
Sauter D, Fernandes S, Goncalves-Mendes N, Boulkroun S, Bankir L, Loffing J, Bouby N (2006) Long-term effects of vasopressin on the subcellular localization of ENaC in the renal collecting system. Kidney Int 69:1024–1032. doi:10.1038/sj.ki.5000211
Bhalla V, Hallows KR (2008) Mechanisms of ENaC regulation and clinical implications. J Am Soc Nephrol 19:1845–1854. doi:10.1681/ASN.2008020225
Svenningsen P, Friis UG, Bistrup C, Buhl KB, Jensen BL, Skøtt O (2011) Physiological regulation of epithelial sodium channel by proteolysis. Curr Opin Nephrol Hypertens 20:529–533. doi:10.1097/MNH.0b013e328348bcc7
Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA (1999) Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest 104:R19–R23
Masilamani S, Wang X, Kim GH, Brooks H, Nielsen J, Nielsen S, Nakamura K, Stoke JB, Knepper MA (2002) Time course of renal Na-K-ATPase, NHE3, NKCC2, NCC and ENaC abundance changes with dietary NaCl restriction. Am J Physiol Ren Physiol 283:F648–F657
Riazi S, Khan O, Tiwari S, Hu X, Ecelbarger C (2006) Rosiglitazone regulates ENaC and Na-K-2Cl cotransporter (NKCC2) in the obese zucker rat. Am J Nephrol 26:245–257
Zhang Y, Carlson NG, Kishore BK, Ecelbarger CM (2013) Pharmacological blockade of P2Y2 receptor reverses lithium-induced downregulation of NKCC2, NCC, and α-ENaC protein abundances in mice (Abstract). J Am Soc Nephrol 24:537A
Acknowledgments
This work was supported by a grant from the US Department of Veterans Affairs Merit Review Program (to B. K. Kishore) and the resources and facilities at the VA SLC Health Care System, Salt Lake City, Utah, and Marriott Cardiovascular Fellowship (to C. M. Ecelbarger). Additional funding sources include National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-64324 (to J. Peti-Peterdi) and an Established Investigator Award from the American Heart Association (to C. M. Ecelbarger).
Conflict of interest
No conflicts of interest, financial or otherwise, are declared by the author(s). Parts of this work were presented at the Kidney Week 2013 of the American Society of Nephrology, October–November 2013, Atlanta, GA, and appeared as a printed abstract in the proceedings of that meeting [49].
Author information
Authors and Affiliations
Corresponding author
Additional information
Carolyn M. Ecelbarger and Bellamkonda K. Kishore contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhang, Y., Peti-Peterdi, J., Heiney, K.M. et al. Clopidogrel attenuates lithium-induced alterations in renal water and sodium channels/transporters in mice. Purinergic Signalling 11, 507–518 (2015). https://doi.org/10.1007/s11302-015-9469-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-015-9469-0